Daniel Von Hoff Selected Research

bis- neodecanoato- 1,2- diaminocyclohexaneplatinum(II)

12/2006

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Von Hoff Research Topics

Disease

33	Neoplasms (Cancer) 11/2022 - 02/2005
10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2008
8	Adenocarcinoma 12/2022 - 07/2011
5	Fatigue 01/2017 - 02/2005
5	Nausea 01/2017 - 12/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2006
3	Stomach Neoplasms (Stomach Cancer) 11/2021 - 01/2016
3	Vomiting 01/2016 - 12/2006
2	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2005
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2021 - 01/2017
2	Carcinogenesis 01/2019 - 10/2009
1	Actinic Keratosis 02/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Esophageal Squamous Cell Carcinoma 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Lymphoma (Lymphomas) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Appendiceal Neoplasms (Appendix Cancer) 02/2017
1	Neutropenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 08/2015
1	Histiocytosis 08/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 08/2015
1	Histiocytic Sarcoma 08/2015
1	Follicular Dendritic Cell Sarcoma 08/2015
1	Erdheim-Chester Disease 08/2015
1	Cholangiocarcinoma 02/2014

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2022 - 06/2013
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
5	Fluorouracil (Carac)FDA LinkGeneric 02/2022 - 12/2006
5	Gemcitabine FDA Link 01/2021 - 01/2008
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2015
3	Phosphotransferases (Kinase)IBA 01/2022 - 10/2009
3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 12/2006
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2022
2	Untranslated RNA (Noncoding RNA)IBA 02/2022 - 10/2021
2	Estrogen ReceptorsIBA 01/2022 - 01/2013
2	Docetaxel (Taxotere)FDA Link 01/2021 - 04/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 02/2014
2	Sunitinib (Sutent)FDA Link 01/2021 - 08/2009
2	LY2603618IBA 01/2017 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2015 - 01/2013
2	Biological ProductsIBA 01/2014 - 02/2013
2	PlatinumIBA 05/2011 - 12/2006
1	KetonesIBA 11/2022
1	NAD (NADH)IBA 11/2022
1	Tricarboxylic AcidsIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	PhytochemicalsIBA 02/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	palbociclibIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	hydrogen sulfite (bisulfite)IBA 11/2021
1	Cell-Free Nucleic AcidsIBA 11/2021
1	(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA 01/2021
1	neratinibIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	SpermineIBA 01/2021
1	PolyaminesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	A-Form DNA (A-DNA)IBA 11/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	ChromatinIBA 01/2019
1	LY2940680IBA 01/2018
1	enavatuzumabIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	TWEAK ReceptorIBA 01/2018
1	EnzymesIBA 01/2018
1	multidrug resistance-associated protein 1IBA 02/2017
1	trifluridine tipiracil drug combinationIBA 01/2017
1	triptolideIBA 01/2017
1	14-O-phosphonooxymethyltriptolide disodium saltIBA 01/2017
1	Checkpoint Kinase 1IBA 01/2017
1	DiterpenesIBA 01/2017
1	ProdrugsIBA 01/2017
1	SolutionsIBA 01/2017
1	TabletsIBA 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	ASG-5MEIBA 01/2016
1	Immune Checkpoint ProteinsIBA 08/2015
1	pazopanib FDA Link 02/2014

Therapy/Procedure

13	Therapeutics 11/2022 - 02/2005
2	Drug Therapy (Chemotherapy) 11/2022 - 02/2005
1	Ketogenic Diet 11/2022